ClinicalTrials.gg
RecruitingNCT06438432Activ'TroncUpdated Aug 27, 2025

Trunk Activity Rehabilitation in Young Children With Cerebral Palsy

An interventional study of RAIT in Children With Cerebral Palsy, sponsored by Union de Gestion des Etablissements des Caisses d'Assurance Maladie - Nord Est. Recruiting at 1 site in France. Open to participants aged 18 Months to 6 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2025-08-27.

Sponsored by Union de Gestion des Etablissements des Caisses d'Assurance Maladie - Nord Est · Not applicable, Interventional, and Treatment

How we know

From the registry’s dates

  • Started Apr 2024; still recruiting 2 years 6 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
32
Allocation
Randomized
Ages
18 Months to 6 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 91 studies in Cerebral Palsy with a site in France — 29 open to participants now, 30 under way, none of them phase 3. Cerebral Palsy · France.

Planned enrollment
33rd of 59
32 · median 36
Started
2024
with 5 others
No phase
48 of 91
20 open now
Primary completion
2026-10
later than 8 of 29 live
Registered
69th of 91
by date
Lead sponsor
4 of 91
Union de Gestion des Etablissements des Caisses d'Assurance Maladie - Nord Est

Among the 91 studies in Cerebral Palsy with a site in France, this one is the 33rd largest by planned enrollment of the 59 interventional ones that give a count, is one of 6 that started in 2024, is one of 48 with no phase, reaches primary completion later than 8 of the 29 other live ones, and was the 69th registered.

Cerebral Palsy

1,942 studies on the registry are indexed under Cerebral Palsy; 456 are open to participants now.

Browse Cerebral Palsy studies →

Open to participants now

29 of the 91 studies in Cerebral Palsy with a site in France are open now. Recruiting first, the newest first:

23 more — sign in →

All 29 open studies →

A study can be open while its sites in France have not opened yet or have stopped. Only those recruiting at a site in France →

Who these studies take

Of the 271 Cerebral Palsy studies recruiting now, 26 (10%) set no upper age limit and 237 (87%) stop at 75 or younger; 256 take children under 18; 53 take healthy volunteers.

This study: 18 Months to 6 Years · all sexes · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 91 studies in Cerebral Palsy with a site in France, or all of them as a file.
02

Study summary

Children with CP exhibit trunk control issues from early childhood, affecting their balance and gait. These issues manifest as unstable walking, increased step width, and more pronounced anterior deceleration of the sternum. Previous studies have shown that early action of the triceps surae compensates for the deficit in trunk postural control. Rehabilitation targeting the trunk has shown significant improvements in postural control and gait.

The main objective is to demonstrate that RAIT (Rehabilitation by Activities Involving the Trunk) significantly reduces the peak anterior deceleration of the sternum at the beginning of the stance phase during barefoot spontaneous walking, with an enhanced effect from prolonged RAIT duration.

Secondary objectives include reducing the downward deceleration of the fifth lumbar vertebra (L5), step width, gait variability index, and improving scores on the early clinical balance scale and the global motor function evaluation.

Participants, children with spastic paraparesis or spastic hemiparesis capable of walking independently, are divided into two groups: one group continuing their usual rehabilitation for 3 months followed by RAIT for 9 months (RH-RAIT), and one group following RAIT for 12 months (RAIT-RAIT). RH involves rehabilitation exercises for lower limb muscles, while RAIT focuses on improving trunk postural control through activities involving intermediate postures.

Functional motor assessments will be conducted initially, then at 3, 6, and 12 months. These include clinical evaluations, gait analysis (step width, gait variability index, anterior foot support), and an analysis of static standing displacement using an inertial sensor placed at L5.

At M0, children with CP are expected to show higher values for deceleration peaks and gait variability indices, and lower scores on evaluation scales compared to typically developing (TD) children. After RAIT, an improvement in judgment criteria is expected: reduction in deceleration peaks, cycle width, gait variability index, anterior foot support, and an increase in scores on the ECPE and EMFG-66-SI.

This study aims to confirm that rehabilitation through trunk-involving activities is more effective than usual rehabilitation in improving postural control and gait dynamics in young children with cerebral palsy, suggesting that this approach could become a standard rehabilitation practice from early childhood.

03

Conditions studied

  • Children With Cerebral Palsy

Browse trials for

04

Who can participate

Ages eligible
18 Months to 6 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

For children with CP

  • Age between 18 months and 5 years 6 months
  • CP type: spastic paraparesis or spastic hemiparesis, GMFCS I to II
  • No or moderate retraction of the sural triceps (ankle dorsiflexion: > 5° on clinical examination, knee straight)
  • Sufficient level of understanding to carry out activities involving the trunk in the form of self-exercises (rehabilitation protocol), as well as clinical assessments and functional explorations.
  • Acceptance by the physiotherapist in charge of the child's follow-up to collaborate in carrying out the RAIT.
  • Affiliated with a social security scheme

For children with DT

  • Age between 18 months and 5 years 6 months
  • Walking acquired before age 18 months
  • Sufficient level of understanding to perform clinical assessments and functional explorations
  • Affiliated with a social security scheme

Exclusion criteria

Exclusion Criteria:

For children with CP

  • Previous surgery on lower limbs less than 1 year ago
  • Botulinum toxin A injection less than 6 months ago
  • Any change in rehabilitative and/or orthopedic management in the last 2 months
  • Hip flessum > 20
  • Presence of subacute or chronic pain on standing or walking

For children with DT

- Neurological and/or orthopedic disorders that may influence gait

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
32 participants (estimated)

Study arms

  • Experimental
    RH-RAIT

    A first group of children will continue their usual rehabilitation (RH) for the first 3 months and then have RAIT for the following 9 months.

    Other: RAIT

  • Experimental
    RAIT-RAIT

    The second group of children will have RAIT from the outset during the 12 months of the study.

    Other: RAIT

Interventions

  • OtherRAIT

    The RAIT program focuses on improving postural control and balance of the entire body, including the trunk and other affected muscles, through autonomous actions in intermediate postures. This approach uses fundamental automatic control of postural support and balance to enhance the use of affected muscles during all postural and locomotor tasks. The child controls their balance during various voluntary actions from intermediate postures like alternating between four-legged and cobra postures, or swinging from the camel posture. These actions, less difficult than standing and walking, are expected to benefit the latter. The child also performs more challenging trunk movements, requiring dissociation of scapular and pelvic girdle movements or reducing lumbar lordosis.

06

What researchers measure

Primary outcomes

  1. Peak anterior deceleration of the sternum at the start of weight-bearing

    Varaible obtained via the analysis of walking on a zeno treadmill. A reduced value is expected after RAIT rehabilitation.

    Time frame: At inclusion, then 3, 6 and 12 months later

Secondary outcomes

  1. EMFG-66-SI

    The Evaluation Motrice Fonctionnelle Globale 66 (EMFG-66) is a standardized 66-item clinical score used to assess global motor function and its evolution over time in children with cerebral palsy. The EMFG-66-SI is a faster (approx. 20 to 30 minutes vs. 60 to 80 minutes), validated scoring method for the EMFG-66, using 15 to 39 items. The higher the score, the better.

    Time frame: At inclusion, then 3, 6 and 12 months later

  2. The Early Clinical Balance Scale

    This is a 13-item clinical scale for assessing postural stability (balance ability) in children with cerebral palsy, with two subscales: one dedicated to head and trunk postural control, the other to sitting and standing postural control.The scale has been validated for children aged 1.5 to 11, regardless of GMFCS level (40,47). The scale has been validated for children aged 1.5 to 11, regardless of GMFCS level.)The optimal score is 100. Administering the scale takes around 15 minutes. The higher the score, the better.

    Time frame: At inclusion, then 3, 6 and 12 months later

  3. Global Motor Function Classification System family report questionnaire

    This questionnaire for parents, based on the child's voluntary movements for sitting, transferring and mobility, provides a 5-level classification of the severity of the child's cerebral palsy. Score between 1 and 5. The higher the score, the more severe the cerebral palsy.

    Time frame: At inclusion

  4. "Reach out" questionnaire

    This is a questionnaire designed for parents to assess the upper limb and hand abilities in different functional situations of their child with CP. This questionnaire, validated for children with CP from the age of 2, will help to assess the expected improvement in hand and upper limb function linked to RAIT. The higher the score, the better.

    Time frame: At inclusion, then 3, 6 and 12 months later

  5. Neuro-orthopaedic assessment

    This examination consists of measuring the amplitude of movement of the main joints in one or more planes, using a goniometer. Check against standards for each joint

    Time frame: At inclusion, then 3, 6 and 12 months later

  6. Neuro-orthopaedic assessment

    This examination consists of measuring spasticity of the main muscles, by mobilizing a joint at slow and then fast speed to elicit a stretch reflex. Score between 0 and 4. 4 indicates the highest level of spasticity.

    Time frame: At inclusion, then 3, 6 and 12 months later

  7. Neuro-orthopaedic assessment

    This examination consists of measuring the muscular strength of the main muscle groups, by asking the subject to mobilize a joint against resistance. Score between 0 and 5. The higher the score, the better.

    Time frame: At inclusion, then 3, 6 and 12 months later

  8. peak downward deceleration of L5 at the start of support

    varaible obtained via the analysis of walking on a zeno treadmill. A reduced value is expected after RAIT rehabilitation.

    Time frame: At inclusion, then 3, 6 and 12 months later

  9. Gait variability index

    Composite score based on 9 spatio-temporal parameters that quantifies the distance between the amount of variability observed in an asymptomatic reference group and the amount of variability observed in the patient. This index assesses gait instability and the risk of falling. It is usually high in children with CP.

    Time frame: At inclusion, then 3, 6 and 12 months later

  10. Cycle width

    Varaible obtained via the analysis of walking on a zeno treadmill. A reduced value is expected after RAIT rehabilitation.

    Time frame: At inclusion, then 3, 6 and 12 months later

  11. Anterior support of the foot during 1st double support

    Ratio between the integrated pressure of the forefoot and the integrated pressure of the whole foot during the 1st double support. This variable will be higher the more the foot is supported on the ground by the forefoot, as in the PC child, and lower the more the foot is supported by the heel, as in the typically developing child.

    Time frame: At inclusion, then 3, 6 and 12 months later

  12. Edinburgh walk visual score

    Score developed for children with cerebral palsy, assessing the extent of kinematic deviations compared to typically developing children. (0 = normal, 1 = moderate or mild pathology, 2 = severe pathology). So 0 here means the best EVGS score.

    Time frame: At inclusion, then 3, 6 and 12 months later

07

Study locations

1 of 1 sites recruiting
08

References and documents

Publications

  • Zografou S, Pierret J, Vasa R, Paysant J, Beyaert C. Investigating rehabilitation by activities involving the trunk to improve balance and gait control in young children with cerebral palsy: A randomized open-label crossover trial protocol. PLoS One. 2026 Mar 13;21(3):e0334195. doi: 10.1371/journal.pone.0334195. eCollection 2026. PubMed 41824540 ↗

Individual participant data

Plan to share: No

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Apr 2024 (actual). Primary completion is estimated for Oct 2026, 30 months after the start.

Of 906 non-industry interventional studies with no phase under Cerebral Palsy, half reached primary completion within 12 months of starting (the median), counting those still running; a quarter within 5 and three quarters within 31. This study's planned 30 months is above that.

Counting every sponsor, half of 925 studies reached it within 12 months; a quarter within 5 and three quarters within 31.

How these figures are worked out, and which studies are left out of them.

Registered
May 27, 2024
First posted
May 31, 2024
StartActual
Apr 25, 2024
Primary completionEst.
Oct 31, 2026
CompletionEst.
Oct 31, 2026
Last update
Aug 27, 2025
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Aug 27, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06438432
Lead sponsor
Union de Gestion des Etablissements des Caisses d'Assurance Maladie - Nord Est
Responsible party
Sponsor
First posted
May 31, 2024
Start date
Apr 25, 2024
Primary completion
Oct 31, 2026 (estimated)
Completion
Oct 31, 2026 (estimated)
Last update
Aug 27, 2025

Study contacts

Jonathan Pierret, PhD
Contact
jonathan.pierret@ugecam.assurance-maladie.fr
+33 3 83 52 6761
Christian Beyaert, PU-PH
Contact

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion